PER 1.25% 7.9¢ percheron therapeutics limited

Ann: US FDA Type C Meeting for ATL1102 in DMD, page-25

  1. 4,683 Posts.
    lightbulb Created with Sketch. 1086
    Jesus Akki - read the ann.

    "monkeys" ..... is still related to 'clinical' reqs.

    The FDA would not provide positive 'guidance' for 'clinical' reqs, if there was an issue with tox in monkeys.

    They have human tox data from 9 DMD boys over 6 month period - that is much more significant and relevant.

    They are talking about 'non clinical' reqs.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.9¢
Change
-0.001(1.25%)
Mkt cap ! $72.57M
Open High Low Value Volume
7.9¢ 8.1¢ 7.9¢ $25.39K 318.9K

Buyers (Bids)

No. Vol. Price($)
1 26000 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 19076 1
View Market Depth
Last trade - 14.48pm 16/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.